1 / 7

Antibody Production Market: Customer Preferences and Buying Patterns

Global Market Insights adds a new report Global Antibody Production Market Research Report for the period of 2024-2032 that shows the growth of the market is rising at a Steady CAGR to 2032.

Ashwin19
Download Presentation

Antibody Production Market: Customer Preferences and Buying Patterns

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Antibody Production Market Size 2032 - By Application, Type & Manufacturers Across North America, Europe, APAC, South America, MEA

  2. Industry Insights • Global Antibody Production Market share will expand at 11.8% CAGR from 2023 to 2032, driven by the increasing R&D expenditure in pharmaceutical and biotechnology companies. • Elevated investment in research and development allows for the exploration of novel antibody therapies, improved production processes, and expanded applications in diagnostics and therapeutics. • This drives innovation, product development, and the emergence of advanced technologies. Additionally, strong market competition and the need to stay ahead in a rapidly evolving field motivate companies to allocate resources for R&D. • For instance, in June 2023, Sun Pharmaceutical Industries, a leading global pharmaceutical company, revealed its intention to boost investments in clinical trials and innovation within its generic and specialty sectors.

  3. This expanded expenditure will be primarily directed toward developing new applications for dermatology products like Deuruxotinib and Ilumya, along with further research into the diabetes drug GLP-1. • The company has disclosed that it currently possesses a generics pipeline comprising 97 Abbreviated New Drug Applications (ANDAs) for the US market. Additionally, there are 13 new drug applications awaiting approval from the US FDA. • Such investments will collectively shape the future growth of the antibody production industry and foster its potential to address a broader range of medical conditions. • The polyclonal antibodies production industry will experience significant growth over 2023-2032, driven by the expanding use of antibodies in research, diagnostics, and therapeutics. The industry also benefits from advancements in biotechnology, enabling more efficient production processes. • Additionally, the development of personalized medicine and immunotherapies fuels the need for specific antibodies. Overall, the versatile and widespread applications of polyclonal antibodies continue to shape the industry's growth.

  4. Regional Analysis • Asia Pacific antibody production industry is thriving and will record a decent CAGR through 2032. This growth can be attributed to the expanding biotechnology and pharmaceutical sectors, increased investment in research and development, and a growing demand for antibody-based therapies and diagnostics. Additionally, the presence of skilled scientific talent and a competitive manufacturing environment make the Asia Pacific an attractive hub for antibody production, fostering its flourishing in the region. • Competitive Analysis • Thermo Fisher Scientific, Inc. • GE Healthcare • Merck KGaA • Sartorius AG • Eppendorf AG • Danaher Corporation

  5. Antibody Production Market@ https://www.gminsights.com/industry-analysis/antibody-production-market Request for sample of this research report @ https://www.gminsights.com/request-sample/detail/6490 Request for customization @ https://www.gminsights.com/roc/6490

  6. Stay In Touch Social Media:

  7. THANK YOU www.gminsights.com

More Related